Create BioVentures Strengthens Support System for Commercialization of Academia-Originating Drug Discovery Seeds

Create BioVentures Strengthens Support System for Commercialization of Academia-Originating Drug Discovery Seeds

Create BioVentures, Inc. (Headquarters: Shinjuku-ku, Tokyo; Representative Director: Goshi Ozawa; hereinafter "CBV") is pleased to announce that, to strengthen its support system for the commercialization of academia-originating drug discovery seeds, Dr. Kotone Matsuyama, Director of the Clinical Research Center at the National Center for Child Health and Development, will join the company as an advisor, effective July 1, 2026.

Dr. Matsuyama will provide advice on CBV's business development from the perspectives of clinical research, regulatory affairs for development, project management, and commercialization of academia-originating seeds. CBV will further enhance its support functions for nurturing research outcomes into businesses that reach patients.

Background

While many excellent drug discovery seeds are born in Japanese universities and research institutions, there remains a significant gap in the process of evaluating them in the context of drug development and connecting them to commercialization, company formation, partnerships with pharmaceutical companies, fundraising, and the integration of management talent.

From a neutral standpoint, without the capital of specific pharmaceutical companies or its own research facilities, CBV supports the creation and nurturing of drug discovery startups that reach patients by connecting academia-originating drug discovery seeds to commercialization, company formation, partnerships with pharmaceutical companies, connections with VCs/financial institutions, and networks of management talent/experts.

By having Dr. Matsuyama, who has extensive experience in clinical research, regulatory affairs for development, project management, industry-academia collaboration, and human resource development, join as an advisor, CBV will further strengthen its support functions for the commercialization of academia-originating drug discovery seeds.

Profile of Kotone Matsuyama

Kotone Matsuyama, appointed CBV Advisor

Graduated from the Faculty of Pharmacy, Kyoto University in 2000 and obtained a pharmacist license. She has held positions at the Exploratory Medical Center (now the Comprehensive Clinical Research Center), Kyoto University Hospital, the Advanced Medical Research Foundation in October 2003, Kyoto Prefectural University of Medicine in April 2015, Specially Appointed Professor of Healthcare Management at Nippon Medical School in October 2017, and Deputy Director of the Research Management Center at Nippon Medical School Foundation in November of the same year, before becoming Director of the Clinical Research Center at the National Center for Child Health and Development in June 2025. She continues in this role today.

She has experience in departments such as data management, medical writing, intellectual property/academic research, and project management, and is currently involved in the regulatory affairs management for the development of academia-originating seeds and coordination of industry-academia collaboration. Her expertise lies in clinical pharmacology and project management.

She is also responsible for research ethics and organizational governance within the institution. She serves as a director of the Japanese Society for Pharmaceutical Medicine. She has obtained domestic and international professional qualifications in pharmaceutical medicine and is also involved in the education of pharmaceutical medicine professionals, including as a lecturer for the PharmaTrain course.

【Major Qualifications and Positions】 ・Certified Professional in Pharmaceutical Medicine (Certified by the Japanese Society for Pharmaceutical Medicine) ・Global Fellow in Medicines Development (GFMD, IFAPP) ・International Society for Pharmaceutical Medicine (IFAPP) President Elect (from April 2025) ・DIA Japan Contents Committee Lead (from January 2024 to present) ・AMED Program Officer for the Promotion of Infrastructure for the Practical Application of Regenerative Medicine (from April 2024 to present)

Comment from Dr. Matsuyama

To connect research outcomes generated in academia to medical treatments that reach patients, a multifaceted perspective is crucial, including not only assessing scientific value but also clinical research, regulatory affairs for development, project management, and industry-academia collaboration.

I will leverage my experience to contribute to Create BioVentures' initiatives aimed at the commercialization and societal implementation of academia-originating drug discovery seeds.

Comment from Representative Goshi Ozawa

Representative Goshi Ozawa

To nurture academia-originating drug discovery seeds into businesses that reach patients, it is essential not only to assess the value of research outcomes but also to have an implementation perspective that includes clinical research, regulatory affairs for development, project management, industry-academia collaboration, and patient and citizen engagement.

With Dr. Matsuyama joining as an advisor, we will further strengthen the functions that Create BioVentures aims for, making the path from the laboratory to the patient more certain.

About Create BioVentures, Inc.

Create BioVentures, Inc. is a drug discovery startup creation platform that co-creates drug discovery startups reaching patients by connecting academia-originating drug discovery seeds with knowledge, technology, people, and capital.

From a neutral position, without the capital of specific pharmaceutical companies or its own research facilities, we provide integrated support for disease/patient value, intellectual property, preclinical/clinical development, regulatory affairs, business viability, fundraising, and partnership strategies, accompanying research outcomes through to societal implementation.

Create BioVentures, Inc. Logo

Company Name: Create BioVentures, Inc. Location: 2-5-5 Wakaba, Shinjuku-ku, Tokyo Representative: Goshi Ozawa, Representative Director Business Activities: Support for commercialization of drug discovery seeds, support for creation of drug discovery startups, support for collaboration with pharmaceutical companies, investors, and management talent, and other related businesses.

Website: https://createbioventures.co.jp/

Official LinkedIn Page: https://www.linkedin.com/company/createbioventures/

Contact Information for this Matter

Create BioVentures, Inc.

E-mail: contact@createbioventures.co.jp

Inquiry Form: https://createbioventures.co.jp/contact/

Website: https://createbioventures.co.jp/

Official LinkedIn Page: https://www.linkedin.com/company/createbioventures/

*This announcement concerns Dr. Matsuyama's appointment as an advisor in her personal capacity and does not indicate an official view or endorsement by her affiliated institution, nor does it signify an organizational collaboration or partnership with Create BioVentures, Inc.